5/2
Internal Medicine
A promising new strategy to help broken bones heal faster
To improve how broken bones heal in people with diabetes, the School of Dental Medicine’s Henry Daniell, Sheri Yang, and colleagues are leading work to develop an affordable oral therapy—grown in plants.
Vasculitis treatment with fewer steroids
The insights from the PEXIVAS Trial, a 10-year study, shows treatment for ANCA-associated vasculitis can become much more patient-friendly and reduces kidney failure, for which vasculitis patients are often at risk.
Advancing an oral drug for pulmonary arterial hypertension
With a protein drug grown in the leaves of lettuce plants, the School of Dental Medicine’s Henry Daniell and colleagues hope to provide new treatment options for patients with pulmonary arterial hypertension, a rare but deadly disease.
Direct-to-consumer fertility tests confuse and mislead consumers
Findings from the small, first-of-its-kind ethnographic study reinforce the need for consumer education around the purpose and accuracy of direct-to-consumer hormone-based fertility tests.
Losing tongue fat improves sleep apnea
A Penn Medicine study suggests the tongue could be a new target for treating the common sleep disorder.
Penn Medicine named official health system of the Philadelphia Flyers
The partnership brings two iconic Philadelphia brands together to collaborate on community-driven initiatives.
Living in poor communities, dying from heart disease
A new study, led by Penn Medicine, found counties that experienced the most economic distress from 2010 to 2015 had the highest cardiovascular mortality rates.
Seven years later, PrEP access remains a challenge
Getting PrEP in the hands of high-risk communities remains a challenge; Penn researchers and practitioners are finding ways to reduce barriers and investigate new forms of the drug.
Predicting treatment outcome for leishmaniasis
In a study of patients treated in Brazil, a team led by School of Veterinary Medicine researchers identified genetic factors and features of the infection itself that predict whether patients will respond to treatment.
Tall people: Your hearts are at risk
The research team reveals a strong link between the genetic variants associated with height and one’s risk for arterial fibrillation, and is among the first to demonstrate that height may be a causal—not correlated—risk factor for the condition.
In the News
Cannabis reclassification could be game-changer for U.S. drug policy
Michael Cirigliano of the Perelman School of Medicine says that marijuana deserves to be removed from the same category as LSD, heroin, and fentanyl.
FULL STORY →
Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
Potential mpox exposure at school in Port Richmond causes parents to worry: What to know about the virus
Michael Cirigliano of the Perelman School of Medicine says that monkeypox spreads mostly through skin-to-skin contact, though the risk of exposure in normal settings is low.
FULL STORY →
Marc Satalof donated 35 gallons of blood in more than 50 years. At 76, the Montco retiree just rolled up his sleeve for the last time
A longtime Philadelphia schoolteacher has completed his final donation of blood at Penn’s Perelman Center for Advanced Medicine, with remarks from Kristin G. Christensen and Donald Siegel of the Perelman School of Medicine.
FULL STORY →
Why is my dog sneezing a lot? What’s normal and when to worry
Paolo Silvestrini of the School of Veterinary Medicine says that the most frequent reasons for abrupt, sudden canine sneezing may involve a foreign body or allergic reactions to environmental allergens.
FULL STORY →
1 in 4 inmate deaths happens in the same federal prison. Why?
David Vaughn of the Perelman School of Medicine says a delay in diagnosis of testicular cancer of more than six months is an independent predictor of a lower chance of survival.
FULL STORY →